Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Category: Diabetes

1462-P: Hyperbaric Oxygen Therapy as an Adjunct to Standard Medical and Surgical Care for Diabetic Foot Ulcers: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

June 21, 2026 by sugaradmin

Introduction and Objective: Diabetic foot ulcers (DFUs) remain a major complication of diabetes associated with impaired healing and amputation risk. Hyperbaric oxygen therapy (HBOT) has been proposed as an adjunctive treatment, but evidence continues to evolve. The objective of this updated systematic review and meta-analysis is to analyze the efficacy of hyperbaric oxygen for the […]

Read More
DiabetesLeave a Comment on 1462-P: Hyperbaric Oxygen Therapy as an Adjunct to Standard Medical and Surgical Care for Diabetic Foot Ulcers: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

2701-LB: Independent Prognostic Value of the Novel Early Biomarker uPTM-FetA/Ucr in Diabetic Kidney Disease: Overcoming Treatment Confounders in a Real-World Cohort

June 21, 2026 by sugaradmin

Introduction and Objective: Accurate risk stratification in Diabetic Kidney Disease (DKD) is often confounded by nephroprotective medications (e.g., SGLT2i) and the non-linear dynamics of traditional biomarkers in advanced stages. This study evaluated the disease specificity and independent prognostic value of a novel biomarker, uPTM-FetA/Ucr, across the diabetes disease continuum, in a real-world cohort.Methods: A cross-sectional […]

Read More
DiabetesLeave a Comment on 2701-LB: Independent Prognostic Value of the Novel Early Biomarker uPTM-FetA/Ucr in Diabetic Kidney Disease: Overcoming Treatment Confounders in a Real-World Cohort

1980-P: Cost Burden of Diabetic Foot Ulcer and Amputation under Modeled Treatment Discontinuation in Painful Diabetic Peripheral Neuropathy

June 21, 2026 by sugaradmin

Introduction and Objective: Treatment discontinuation in painful diabetic peripheral neuropathy (PDPN) is common and may result in periods without active therapy. We used a decision tree model to evaluate how discontinuation patterns influence risk of diabetic foot ulcer (DFU), amputation, and costs.Methods: A decision tree simulated 1,000 adults initiating PDPN therapies modeling periods without treatment. […]

Read More
DiabetesLeave a Comment on 1980-P: Cost Burden of Diabetic Foot Ulcer and Amputation under Modeled Treatment Discontinuation in Painful Diabetic Peripheral Neuropathy

2526-P: Diabetes, but Not Isolated Respiratory Disease, Couples Metabolic and Inflammatory Biomarkers

June 21, 2026 by sugaradmin

Introduction and Objective: Diabetes and chronic respiratory diseases (RD) frequently coexist and share inflammatory features. However, whether metabolic dysfunction similarly influences inflammatory and vascular profiles across these conditions is unclear.Methods: We investigated shared and disease-specific metabolic inflammatory patterns in diabetes, RD, and their coexistence. We analyzed 262 subjects after excluding major confounders. Participants were classified […]

Read More
DiabetesLeave a Comment on 2526-P: Diabetes, but Not Isolated Respiratory Disease, Couples Metabolic and Inflammatory Biomarkers

1975-P: Experiences of People with Diabetes (PwD) Regarding Prior Authorization (PA) for Diabetes Care

June 21, 2026 by sugaradmin

Introduction and Objective: PA is often required for diabetes medications and technologies, but its impact on PwD is not well characterized. This study examined the perspectives of PwD regarding the PA process in diabetes care.Methods: A cross-sectional, anonymous survey was conducted among PwD aged ≥18 years or caregivers of children with diabetes in the U.S. […]

Read More
DiabetesLeave a Comment on 1975-P: Experiences of People with Diabetes (PwD) Regarding Prior Authorization (PA) for Diabetes Care

2525-P: HbA1c Determines Serum Proteomic Response to Acute Exercise in Type 1 Diabetes

June 21, 2026 by sugaradmin

Introduction and Objective: High HbA1c is linked to lower aerobic exercise capacity (VO2peak), even when exercise-training levels are matched, suggesting hyperglycemia may alter the adaptive response to exercise. Each acute bout of exercise induces changes in circulating proteins that mediate exercise response. We determined how T1D alters circulating proteins at rest and with exercise and […]

Read More
DiabetesLeave a Comment on 2525-P: HbA1c Determines Serum Proteomic Response to Acute Exercise in Type 1 Diabetes

1016-OR: Continuous Glucose Monitoring (CGM) Coverage Policy, Access, and Utilization in Nonprofit Community Health Plans

June 21, 2026 by sugaradmin

Introduction and Objective: The Alliance of Community Health Plans (ACHP) is a nonprofit trade association representing nonprofit community health plans. To advance its Chronic Disease Pledge to improve diabetes outcomes by 2030, ACHP members worked together with the International Diabetes Center to understand payer policies related to continuous glucose monitoring (CGM). This project, supported by […]

Read More
DiabetesLeave a Comment on 1016-OR: Continuous Glucose Monitoring (CGM) Coverage Policy, Access, and Utilization in Nonprofit Community Health Plans

2524-P: Acute Glycemic Variability and Outcome in Sepsis: A Prospective Study

June 21, 2026 by sugaradmin

Introduction and Objective: Emerging evidence suggests that glycemic variability may influence outcomes in sepsis. Our objective was to investigate the correlation between acute glycemic variability and mortality as well as other clinical outcomes in sepsis.Methods: Patients aged 18 years or older with sepsis were enrolled in this prospective observational study during 2024-2025. Capillary blood glucose […]

Read More
DiabetesLeave a Comment on 2524-P: Acute Glycemic Variability and Outcome in Sepsis: A Prospective Study

1656-P: TEPLI-REAL: A Real-World Retrospective Study Characterizing Screening and Treatment Patterns for Type 1 Diabetes (T1D) in Individuals Treated with Teplizumab in the U.S.

June 21, 2026 by sugaradmin

Introduction and Objective: Teplizumab (TPZ), an anti-CD3 monoclonal antibody, is approved in the US to delay stage 3 T1D onset in individuals aged ≥8 years (y) with stage 2 T1D. We present screening and real-world treatment (Tx) patterns from individuals in the US who received TPZ according to their age group.Methods: TEPLI-REAL (NCT06892002) was a […]

Read More
DiabetesLeave a Comment on 1656-P: TEPLI-REAL: A Real-World Retrospective Study Characterizing Screening and Treatment Patterns for Type 1 Diabetes (T1D) in Individuals Treated with Teplizumab in the U.S.

2523-P: Early Glycemic Deterioration and Baseline Risk Prediction of Insulin-Like Growth Factor-1 Receptor Inhibitor Therapy

June 21, 2026 by sugaradmin

Introduction and Objective: Insulin-like growth factor-1 receptor (IGF-1R) inhibitor has been developed as an effective therapy for thyroid eye disease (TED). However, treatment-associated hyperglycemia remains a clinical concern. We aimed to examine whether early glycemic deterioration during IGF-1R inhibitor therapy is associated with subsequent glycemic trajectories and to develop and validate a risk prediction model.Methods: […]

Read More
DiabetesLeave a Comment on 2523-P: Early Glycemic Deterioration and Baseline Risk Prediction of Insulin-Like Growth Factor-1 Receptor Inhibitor Therapy

Posts navigation

Older posts
Newer posts

Recent Posts

  • After GLP-1s Quit Working, He Lost 80 Pounds with a Simple Procedure
  • Perimenopause: Can Regular Exercise Improve Your Symptoms?
  • GLP-1 Side Effects vs. Benefits: Real Patient Experiences
  • Menopause: ADHD Medications May Reduce Brain Fog
  • Migraine: Endometriosis Linked to More Than Double the Risk

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness